News
TEVA ▼ -3.7% - Teva Pharmaceutical Industries Limited
TEVA ▼ -3.7% - Teva Pharmaceutical Industries Limited
$TEVA - Teva to Discontinue Phase 2 TOPAS-MSA Study of emrusolmin (TEV-‘286) Following Interim Futility Analysis
02-NOV-2026 08:00 AM ET
Share this post
More filings for $TEVA
TEVA - Teva Pharmaceutical Industries Limited - SEC Filing Update (02-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 2, 2026TEVA ▲ +0.1% - Teva Pharmaceutical Industries LimitedOct 27, 2026TEVA ▲ +1.4% - Teva Pharmaceutical Industries LimitedOct 20, 2026TEVA ▲ +0.5% - Teva Pharmaceutical Industries LimitedOct 12, 2026TEVA ▲ +4.0% - Teva Pharmaceutical Industries LimitedOct 9, 2026TEVA ▲ +3.2% - Teva Pharmaceutical Industries LimitedOct 9, 2026
View full $TEVA filing history →💬 Comments
Loading comments…
Leave a comment